GST Exemption for Essential Medicines

Exemption Details: Certain medicines exempted from Union territory tax under section 7 of the UTGST Act, 2017.

Medicine Categories: Tocilizumab, Amphotericin B, Remdesivir, Heparin, Talizumab, Posaconazole, Infliximab, Bamlanivimab & Etesevimab, Casirivimab & Imdevimab, 2-Deoxy-D-Glucose, Favipiravir.

Tax Rate: Varied rates applied, ranging from nil to 2.5% based on specific medicines.

Effective Period: Exemption applicable from October 1, 2021, until December 31, 2021, to address public health needs.

Government Authority: Notification issued by Rajeev Ranjan, Under Secretary to the Government of India, ensuring official endorsement.

Relief Measures: Aimed at reducing the financial burden on patients accessing essential medicines during specified period.

Healthcare Support: Reflects government's commitment to supporting healthcare accessibility and affordability during challenging times.